MarketInOut Stock Screener Log In | Sign Up

OncoTherapy Science Inc

TSE • Healthcare • Biotechnology • Quote as of 10/30/2026
OncoTherapy Science Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization7,348.38 mln
Float365 mln
Earnings Date08/07/2025

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.4
Reliable

Relative Strength

75 / 100
Strongly outperforming

Pre-Tax Margin

-114%
Severely loss-making

ROE

-47.31
Deeply negative

Altman Z-Score

4.65
Strong

Business Description

OncoTherapy Science Inc. is a Japanese biotechnology company focused on developing new treatments for cancer and other serious diseases, including drugs derived from antibodies, cancer vaccines, and small molecule compounds. Founded in 2001 and based in Kawasaki, Japan, the company also conducts genomic research and liquid biopsy analysis to advance cancer detection and immunotherapy. Several of its treatments are currently progressing through clinical trials, targeting conditions such as leukemia, breast cancer, and gastric cancer, among others.

Key Fundamentals

EPS-2.37
ROE-47.31
RPS2.17
ROIC-305
ROA-40.53
Interest Cover-631
EBITDA, mln-882
EV / EBITDA-6.89
EV / EBIT-6.89
Revenue, mln778
EV / Revenue7.81

Quote Details

Last 18.00
Change 1 (5.88%)
Open 17.00
Volume 220,929,504
Turnover 3,976,731,136
Average Volume 201,902,016

Financial Ratios

Pre-Tax Profit Margin-114
Leverage Ratio1.11
Current Ratio11.81
Price / Book3.65
Price / Tangible Book3.65
Price / Sales9.72

Financial Strength

Altman Z-Score4.65
Piotroski F-Score 4 / 9
Beneish M-Score-3.4

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 62 / 100   
1 Month -14.29% 11 / 100   
2 Months -10% 18 / 100   
6 Months -28% 7 / 100   
1 Year -21.74% 13 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog